MSV
JAZZ icon

MN Services Vermogensbeheer’s Jazz Pharmaceuticals JAZZ Stock Holding History

MN Services Vermogensbeheer’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-30,017
Closed -$4.39M – 466
2023
Q1 		$4.39M Hold
30,017
– – 0.05% 352
2022
Q4 		$4.78M Sell
30,017
-3,600
-11% -$528K 0.05% 339
2022
Q3 		$4.48M Sell
33,617
-2,600
-7% -$395K 0.05% 360
2022
Q2 		$5.65M Sell
36,217
-6,400
-15% -$985K 0.05% 358
2022
Q1 		$6.63M Sell
42,617
-1,900
-4% -$276K 0.04% 338
2021
Q4 		$5.67M Hold
44,517
– – 0.03% 363
2021
Q3 		$5.8M Hold
44,517
– – 0.04% 387
2021
Q2 		$6.67M Buy
+44,517
New +$7.71M 0.05% 340
2020
Q4 		$7.89M Buy
+47,817
New +$7.12M 0.06% 285
2020
Q3 		– Sell
-47,817
Closed -$5.28M – 337
2020
Q2 		$5.28M Sell
47,817
-600
-1% -$66.3K 0.05% 306
2020
Q1 		$4.83M Sell
48,417
-3,100
-6% -$401K 0.05% 268
2019
Q4 		$7.69M Buy
51,517
+1,800
+4% +$245K 0.07% 272
2019
Q3 		$6.37M Buy
49,717
+20,073
+68% +$2.69M 0.06% 292
2019
Q2 		$4.23M Sell
29,644
-3,300
-10% -$443K 0.05% 383
2019
Q1 		$4.71M Buy
32,944
+300
+0.9% +$39.1K 0.05% 349
2018
Q4 		$3.54M Buy
32,644
+23,317
+250% +$3.46M 0.05% 351
2018
Q3 		$1.57M Hold
9,327
– – 0.04% 501
2018
Q2 		$1.61M Hold
9,327
– – 0.04% 489
2018
Q1 		$1.41M Hold
9,327
– – 0.04% 521
2017
Q4 		$1.05M Sell
9,327
-400
-4% -$55.5K 0.03% 558
2017
Q3 		$1.42M Hold
9,727
– – 0.04% 510
2017
Q2 		$1.51M Buy
9,727
+8,126
+508% +$1.24M 0.04% 480
2017
Q1 		$217K Buy
1,601
+44
+3% +$5.73K 0.04% 473
2016
Q4 		$161K Hold
1,557
– – 0.03% 536
2016
Q3 		$189K Buy
1,557
+37
+2% +$4.99K 0.04% 504
2016
Q2 		$193K Hold
1,520
– – 0.04% 439
2016
Q1 		$174K Buy
+1,520
New +$189K 0.04% 498

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
SC
Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

MN Services Vermogensbeheer's JAZZ Position: Q2 2023 in Review

MN Services Vermogensbeheer sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2023, closing a stake of 30,017 shares — an estimated $4.39M sold.

MN Services Vermogensbeheer first reported a position in JAZZ in Q1 2016 and held it in 27 quarters. The position peaked at $7.89M in Q4 2020. 471 funds tracked by Wall St. Rank hold JAZZ as of Q2 2023.

  • MN Services Vermogensbeheer reported no remaining Jazz Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • MN Services Vermogensbeheer sold 30,017 Jazz Pharmaceuticals shares in Q2 2023, an estimated $4.39M.
  • MN Services Vermogensbeheer first reported a position in Jazz Pharmaceuticals in Q1 2016 and held it in 27 quarters.
  • MN Services Vermogensbeheer's Jazz Pharmaceuticals position peaked at $7.89M in Q4 2020.
  • 471 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2023.

Based on MN Services Vermogensbeheer's 13F filing for Q2 2023, filed 9 Aug 2023.